RSS
drug target
UK biopharma company completes funding round to enter drug discovery
UK-based biopharmaceutical company, PhoreMost, has completed a Series A investment round worth £11 million, which will be used to expand operations on the Babraham Research Campus and progress several novel drug targets. Read more
Collaborative agreement signed for identification of novel drug targets
PhoreMost, UK-based biopharmaceutical company, has signed a collaborative agreement with Plexxikon, the small molecule structure-guided R&D centre of Daiichi Sankyo, for the identification of novel drug targets. Read more
Scottish researchers unveil potential new drug target for toxoplasmosis
Researchers from the University of Glasgow have discovered a potential new drug target for the parasitic disease, toxoplasmosis. Read more